Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283793145> ?p ?o ?g. }
- W4283793145 abstract "Context Pulmonary arterial hypertension (PAH) is a frequent extracutaneous manifestation of systemic sclerosis (SSc). PAH is characterized by increased vasomotor tone, progressive remodeling of pulmonary arteries and arterioles, consequentially increased pulmonary vascular resistance, right heart hypertrophy, and eventually right ventricular failure. Autoimmunity against G-protein coupled receptors (GPCRs) has been implicated in the development of SSc-associated PAH. Sphingosine-1-phosphate (S1P) receptors (S1PR) present a potential, yet so far untested antigen for PAH autoimmunity, given the documented role of S1P/S1PR signaling in PAH pathogenesis. Objective We hypothesized that S1P receptors (S1PR) may constitute autoantigens in human patients, and that the prevalence of autoantibodies (aAb) to S1PR1, S1PR2 and S1PR3 is elevated in SSc patients and associated with PAH. Methods For this exploratory study, serum samples from 158 SSc patients, 58 of whom with PAH, along with 333 healthy control subjects were screened for S1PR-aAb. S1PR1-3 were expressed as fusion proteins with luciferase in human embryonic kidney cells and used to establish novel in-vitro assays for detecting and quantifying S1PR-aAb. The fusion proteins were incubated with serum samples, the aAb-S1PR complexes formed were precipitated by protein-A, washed and tested for luciferase activity. Commercial anti-S1PR-antibodies were used to verify specificity of the assays. Results All three assays showed dose-dependent signal intensities when tested with S1PR-subtype specific commercial antibodies. Natural aAb to each S1PR were detected in healthy controls with a prevalence of <10% each, i.e., 2.7% for S1PR1-aAb, 3.6% for S1PR2-aAb, and 8.3% for S1PR3. The respective prevalence was higher in the cohort of SSc patients without PAH, with 17.1% for S1PR1-aAb, 19.0% for S1PR2-aAb, and 21.5% for S1PR3. In the subgroup of SSc patients with PAH, prevalence of aAb to S1PR2 and S1PR3 was further elevated to 25.9% for S1PR2-aAb, and 27.6% for S1PR3. Notably, the majority of patients with positive S1PR2-aAb (60.7%) or S1PR3-aAb (71.9%) displayed interstitial lung disease. Conclusion S1PR1–3 can constitute autoantigens in humans, particularly in SSC patients with PAH. The potential pathophysiological significance for the etiology of the disease is currently unknown, but the elevated prevalence of S1PR2-aAb and S1PR3-aAb in SSC patients with PAH merits further mechanistic investigations." @default.
- W4283793145 created "2022-07-05" @default.
- W4283793145 creator A5003825858 @default.
- W4283793145 creator A5017467815 @default.
- W4283793145 creator A5024940207 @default.
- W4283793145 creator A5035844667 @default.
- W4283793145 creator A5039661235 @default.
- W4283793145 creator A5040092311 @default.
- W4283793145 creator A5053033043 @default.
- W4283793145 creator A5057084369 @default.
- W4283793145 date "2022-07-04" @default.
- W4283793145 modified "2023-09-30" @default.
- W4283793145 title "Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension" @default.
- W4283793145 cites W1206320422 @default.
- W4283793145 cites W1866413456 @default.
- W4283793145 cites W1967642852 @default.
- W4283793145 cites W1971793561 @default.
- W4283793145 cites W1982067488 @default.
- W4283793145 cites W1989584416 @default.
- W4283793145 cites W2003791254 @default.
- W4283793145 cites W2006985918 @default.
- W4283793145 cites W2009021880 @default.
- W4283793145 cites W2011178910 @default.
- W4283793145 cites W2060665196 @default.
- W4283793145 cites W2069038734 @default.
- W4283793145 cites W2069373077 @default.
- W4283793145 cites W2081503020 @default.
- W4283793145 cites W2098824799 @default.
- W4283793145 cites W2106040829 @default.
- W4283793145 cites W2135357068 @default.
- W4283793145 cites W2137116513 @default.
- W4283793145 cites W2410763151 @default.
- W4283793145 cites W2474470790 @default.
- W4283793145 cites W2617402993 @default.
- W4283793145 cites W2624796529 @default.
- W4283793145 cites W2751727948 @default.
- W4283793145 cites W2752094431 @default.
- W4283793145 cites W2760533666 @default.
- W4283793145 cites W2766704126 @default.
- W4283793145 cites W2896089314 @default.
- W4283793145 cites W2902679943 @default.
- W4283793145 cites W2911928659 @default.
- W4283793145 cites W2979067402 @default.
- W4283793145 cites W2981063663 @default.
- W4283793145 cites W2999252847 @default.
- W4283793145 cites W3087233649 @default.
- W4283793145 cites W3095322907 @default.
- W4283793145 cites W3118583265 @default.
- W4283793145 cites W3143325997 @default.
- W4283793145 cites W3146789505 @default.
- W4283793145 cites W3162784420 @default.
- W4283793145 cites W3178237887 @default.
- W4283793145 cites W3191152848 @default.
- W4283793145 cites W3212875841 @default.
- W4283793145 cites W4200156725 @default.
- W4283793145 cites W4200471279 @default.
- W4283793145 cites W4229019148 @default.
- W4283793145 cites W4237193773 @default.
- W4283793145 cites W4244478285 @default.
- W4283793145 doi "https://doi.org/10.3389/fimmu.2022.935787" @default.
- W4283793145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35860272" @default.
- W4283793145 hasPublicationYear "2022" @default.
- W4283793145 type Work @default.
- W4283793145 citedByCount "3" @default.
- W4283793145 countsByYear W42837931452023 @default.
- W4283793145 crossrefType "journal-article" @default.
- W4283793145 hasAuthorship W4283793145A5003825858 @default.
- W4283793145 hasAuthorship W4283793145A5017467815 @default.
- W4283793145 hasAuthorship W4283793145A5024940207 @default.
- W4283793145 hasAuthorship W4283793145A5035844667 @default.
- W4283793145 hasAuthorship W4283793145A5039661235 @default.
- W4283793145 hasAuthorship W4283793145A5040092311 @default.
- W4283793145 hasAuthorship W4283793145A5053033043 @default.
- W4283793145 hasAuthorship W4283793145A5057084369 @default.
- W4283793145 hasBestOaLocation W42837931451 @default.
- W4283793145 hasConcept C126322002 @default.
- W4283793145 hasConcept C134018914 @default.
- W4283793145 hasConcept C140800825 @default.
- W4283793145 hasConcept C146285616 @default.
- W4283793145 hasConcept C167734588 @default.
- W4283793145 hasConcept C170493617 @default.
- W4283793145 hasConcept C203014093 @default.
- W4283793145 hasConcept C2777025900 @default.
- W4283793145 hasConcept C2780130043 @default.
- W4283793145 hasConcept C71924100 @default.
- W4283793145 hasConcept C86803240 @default.
- W4283793145 hasConcept C8891405 @default.
- W4283793145 hasConceptScore W4283793145C126322002 @default.
- W4283793145 hasConceptScore W4283793145C134018914 @default.
- W4283793145 hasConceptScore W4283793145C140800825 @default.
- W4283793145 hasConceptScore W4283793145C146285616 @default.
- W4283793145 hasConceptScore W4283793145C167734588 @default.
- W4283793145 hasConceptScore W4283793145C170493617 @default.
- W4283793145 hasConceptScore W4283793145C203014093 @default.
- W4283793145 hasConceptScore W4283793145C2777025900 @default.
- W4283793145 hasConceptScore W4283793145C2780130043 @default.
- W4283793145 hasConceptScore W4283793145C71924100 @default.
- W4283793145 hasConceptScore W4283793145C86803240 @default.
- W4283793145 hasConceptScore W4283793145C8891405 @default.
- W4283793145 hasFunder F4320320879 @default.